Tus Pharmaceutical Group Co Ltd (000590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.24 Million ≈ $327.43K USD) by net assets (CN¥585.85 Million ≈ $85.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tus Pharmaceutical Group Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Tus Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Tus Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000590 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Tus Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sarana Meditama Metropolitan JK:SAME	0.011x
Biofarm Bucure RO:BIO	0.052x
Jiangxi Everbright Measurement Cont SHE:300906	0.007x
Colonial Coal International Corp V:CAD	-0.023x
Wuhu Conch Profiles and Science Co Ltd SHE:000619	0.030x
Jiangsu Holly Corp SHG:600128	0.038x
Lineage Cell Therapeutics Inc NYSE MKT:LCTX	-0.174x
Thoresen Thai Agencies Public Company Limited BK:TTA	-0.003x

Annual Cash Flow Conversion Efficiency for Tus Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Tus Pharmaceutical Group Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥549.49 Million ≈ $80.41 Million	CN¥28.96 Million ≈ $4.24 Million	0.053x	+82.22%
2024-12-31	CN¥601.23 Million ≈ $87.98 Million	CN¥17.39 Million ≈ $2.54 Million	0.029x	+174.17%
2023-12-31	CN¥728.20 Million ≈ $106.56 Million	CN¥-28.39 Million ≈ $-4.16 Million	-0.039x	-150.29%
2022-12-31	CN¥702.49 Million ≈ $102.80 Million	CN¥54.47 Million ≈ $7.97 Million	0.078x	+109.99%
2021-12-31	CN¥682.32 Million ≈ $99.85 Million	CN¥25.20 Million ≈ $3.69 Million	0.037x	-53.74%
2020-12-31	CN¥644.88 Million ≈ $94.37 Million	CN¥51.48 Million ≈ $7.53 Million	0.080x	+70.04%
2019-12-31	CN¥622.16 Million ≈ $91.04 Million	CN¥29.21 Million ≈ $4.27 Million	0.047x	+4059.95%
2018-12-31	CN¥579.72 Million ≈ $84.83 Million	CN¥654.24K ≈ $95.74K	0.001x	+100.74%
2017-12-31	CN¥583.33 Million ≈ $85.36 Million	CN¥-89.14 Million ≈ $-13.04 Million	-0.153x	-24.06%
2016-12-31	CN¥263.96 Million ≈ $38.63 Million	CN¥-32.51 Million ≈ $-4.76 Million	-0.123x	+58.14%
2015-12-31	CN¥205.79 Million ≈ $30.11 Million	CN¥-60.56 Million ≈ $-8.86 Million	-0.294x	-6.42%
2014-12-31	CN¥184.11 Million ≈ $26.94 Million	CN¥-50.91 Million ≈ $-7.45 Million	-0.277x	-1907.88%
2013-12-31	CN¥269.51 Million ≈ $39.44 Million	CN¥4.12 Million ≈ $603.20K	0.015x	-62.93%
2012-12-31	CN¥478.58 Million ≈ $70.03 Million	CN¥19.75 Million ≈ $2.89 Million	0.041x	-53.10%
2011-12-31	CN¥350.83 Million ≈ $51.34 Million	CN¥30.87 Million ≈ $4.52 Million	0.088x	-71.13%
2010-12-31	CN¥278.88 Million ≈ $40.81 Million	CN¥84.98 Million ≈ $12.43 Million	0.305x	+106.35%
2009-12-31	CN¥231.22 Million ≈ $33.84 Million	CN¥34.14 Million ≈ $5.00 Million	0.148x	+36.63%
2008-12-31	CN¥322.78 Million ≈ $47.23 Million	CN¥34.89 Million ≈ $5.10 Million	0.108x	-51.20%
2007-12-31	CN¥307.22 Million ≈ $44.96 Million	CN¥68.04 Million ≈ $9.96 Million	0.221x	+357.48%
2006-12-31	CN¥271.26 Million ≈ $39.69 Million	CN¥-23.33 Million ≈ $-3.41 Million	-0.086x	-141.28%
2005-12-31	CN¥268.54 Million ≈ $39.30 Million	CN¥55.96 Million ≈ $8.19 Million	0.208x	+15.06%
2004-12-31	CN¥267.57 Million ≈ $39.15 Million	CN¥48.46 Million ≈ $7.09 Million	0.181x	+292.13%
2003-12-31	CN¥259.16 Million ≈ $37.92 Million	CN¥-24.43 Million ≈ $-3.57 Million	-0.094x	-128.08%
2002-12-31	CN¥280.91 Million ≈ $41.11 Million	CN¥94.30 Million ≈ $13.80 Million	0.336x	+283.41%
2001-12-31	CN¥278.65 Million ≈ $40.78 Million	CN¥-51.00 Million ≈ $-7.46 Million	-0.183x	-944.87%
2000-12-31	CN¥380.02 Million ≈ $55.61 Million	CN¥8.23 Million ≈ $1.20 Million	0.022x	+172.82%
1999-12-31	CN¥347.80 Million ≈ $50.89 Million	CN¥-10.35 Million ≈ $-1.51 Million	-0.030x	-305.60%
1998-12-31	CN¥268.78 Million ≈ $39.33 Million	CN¥3.89 Million ≈ $569.06K	0.014x	--

About Tus Pharmaceutical Group Co Ltd

SHE:000590 China Drug Manufacturers - Specialty & Generic

Market Cap

$299.61 Million

CN¥2.05 Billion CNY

Market Cap Rank

#14780 Global

#4365 in China

Share Price

CN¥8.55

Change (1 day)

+3.89%

52-Week Range

CN¥7.71 - CN¥13.09

All Time High

CN¥26.17